Is Orthofix Medical Inc (OFIX) overvalued? · rev $799.5M
Orthofix Medical Inc (OFIX) is a medical devices company listed on US.
This page asks whether Orthofix Medical Inc (OFIX) looks expensive on cached numbers — not a short thesis.
Latest reported OFIX revenue for 2024-12-31 was $799.5M. Net income was -$126.0M. Revenue was up 7.1% from 2023-12-31 to 2024-12-31. OFIX currently screens at market cap $438.0M.
OFIX currently screens at market cap $438.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OFIX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OFIX stock page for the full model, not this heading.
Not investment advice.